Literature DB >> 8930750

Purification of heparin, dermatan sulfate and chondroitin sulfate from mixtures by sequential precipitation with various organic solvents.

N Volpi1.   

Abstract

Heparin, dermatan sulfate and chondroitin sulfate in mixtures were fractionated by sequential precipitation with methanol, ethanol and propanol. The recovered fractions from 0.1 to 2.0 volumes of various solvents were analyzed by agarose-gel electrophoresis and densitometric analysis. Heparins with different relative percentages of slow-moving and fast-moving components were precipitated from 0.5 to 0.7 volumes of methanol, and in this range of volumes, the amount of slow-moving component of heparin decreases and that of the fast-moving species increases. From 0.8 to 1.6 volumes of methanol, mixtures with different percentages of the fast-moving component, dermatan sulfate and chondroitin sulfate are precipitated. Heparin was precipitated from mixtures in the range of 0.1 to 0.4 volumes of ethanol, and from 0.5 to 0.8 volumes mixtures with different relative percentages of dermatan sulfate and chondroitin sulfate were precipitated. From 1.0 to 2.0 volumes of ethanol, high purity (about 100%) chondroitin sulfate can be precipitated. Propanol induces the precipitation of heparin from 0.3 to 0.4 volumes, whilst dermatan sulfate with a purity greater than 85% is precipitated at 0.5 and 0.6 volumes of propanol. 100% chondroitin sulfate is obtained with volumes greater than 0.8. Heparin and chondroitin sulfate from a bovine lung extract of glycosaminoglycans were purified by sequential precipitation with ethanol. The fraction precipitated with 0.4 volumes of ethanol shows greater than 90% heparin and that recovered from 0.9 to 2.0 volumes is composed of 100% chondroitin sulfate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930750     DOI: 10.1016/0378-4347(96)00154-5

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  6 in total

1.  Oversulfated chondroitin sulfate is not the sole contaminant in heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Nat Biotechnol       Date:  2010-03       Impact factor: 54.908

2.  Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Glycobiol Insights       Date:  2010-02-02

Review 3.  From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods.

Authors:  Jan-Ytzen van der Meer; Edwin Kellenbach; Leendert J van den Bos
Journal:  Molecules       Date:  2017-06-21       Impact factor: 4.411

4.  Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol.

Authors:  Damien Balestrino; Mercédès Quintana; Nicolas Charbonnel; Christiane Forestier; Claire Lartigue; Bertrand Souweine
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

5.  Isolation and Chemical Characterization of Chondroitin Sulfate from Cartilage By-Products of Blackmouth Catshark (Galeus melastomus).

Authors:  José Antonio Vázquez; Javier Fraguas; Ramón Novoa-Carvallal; Rui L Reis; Luis T Antelo; Ricardo I Pérez-Martín; Jesus Valcarcel
Journal:  Mar Drugs       Date:  2018-09-20       Impact factor: 5.118

6.  Glycosaminoglycans from Co-Products of «Scyliorhinus canicula»: Extraction and Purification in Reference to the European Pharmacopoeia Requirement.

Authors:  Nawras Talmoudi; Noureddine Ghariani; Saloua Sadok
Journal:  Biol Proced Online       Date:  2020-01-02       Impact factor: 3.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.